Literature DB >> 21564145

Risk-based decision support tools: protecting rail-centered transit corridors from cascading effects.

Michael R Greenberg1, Karen Lowrie, Henry Mayer, Tayfur Altiok.   

Abstract

We consider the value of decision support tools for passenger rail system managers. First, we call for models that follow events along main rail lines and then into the surrounding environment where they can cascade onto connected light rail, bus, auto, truck, and other transport modes. Second, we suggest that both probabilistic risk assessment (PRA-based) and agent-based models have a role to play at different scales of analysis and for different kinds of risks. Third, we argue that economic impact tools need more systematic evaluation. Fourth, we note that developers of decision support tools face a challenge of balancing their desire for theoretical elegance and the tendency to focus only on high consequence events against decisionmakers' mistrust of complex tools that they and their staff cannot manage and incorporate into their routine operations, as well as the high costs of developing, updating, and applying decision support tools to transport systems undergoing budget cuts and worker and service reductions.
© 2011 Society for Risk Analysis.

Mesh:

Year:  2011        PMID: 21564145     DOI: 10.1111/j.1539-6924.2011.01627.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  2 in total

1.  Passenger rail security, planning, and resilience: application of network, plume, and economic simulation models as decision support tools.

Authors:  Michael Greenberg; Paul Lioy; Birnur Ozbas; Nancy Mantell; Sastry Isukapalli; Michael Lahr; Tayfur Altiok; Joseph Bober; Clifton Lacy; Karen Lowrie; Henry Mayer; Jennifer Rovito
Journal:  Risk Anal       Date:  2013-05-29       Impact factor: 4.000

2.  Ten most important accomplishments in risk analysis, 1980-2010.

Authors:  Michael Greenberg; Charles Haas; Anthony Cox; Karen Lowrie; Katherine McComas; Warner North
Journal:  Risk Anal       Date:  2012-05       Impact factor: 4.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.